G, S., G, A., V, C., V, C., CA, P., A, P., . . . A, S. (2025). Association between ranolazine therapy and cognitive decline in elderly patients with ischemic heart disease. Frontiers in pharmacology, 16, 1664988. https://doi.org/10.3389/fphar.2025.1664988
Chicago Style (17th ed.) CitationG, Severini, et al. "Association Between Ranolazine Therapy and Cognitive Decline in Elderly Patients with Ischemic Heart Disease." Frontiers in Pharmacology 16 (2025): 1664988. https://doi.org/10.3389/fphar.2025.1664988.
MLA (9th ed.) CitationG, Severini, et al. "Association Between Ranolazine Therapy and Cognitive Decline in Elderly Patients with Ischemic Heart Disease." Frontiers in Pharmacology, vol. 16, 2025, p. 1664988, https://doi.org/10.3389/fphar.2025.1664988.
Warning: These citations may not always be 100% accurate.
